CyberKnife in Istanbul typically costs from $6,800 to $6,800 based on the tumor location and the required number of treatment sessions. Total costs depend on the technical complexity and necessary diagnostic imaging like PET-CT or MRI. Patients save around 86% compared to the US, where similar procedures cost $55,000 on average. Most Istanbul clinics include medical translation and airport transfers in their initial prices.
Bookimed Expert Insight: Istanbul serves as Turkey's primary oncology hub, offering more specialized radiosurgery centers than Ankara or Antalya. High-value care is found at centers with US-clinical ties, like Anadolu Medical Center, which is affiliated with Johns Hopkins Hospital. Medipol Mega University Hospital also offers strong value by concentrating multiple technologies like CyberKnife and Gamma Knife in one facility. This technical depth lets doctors choose the most effective, rather than the most available, treatment.
| Turcja | Austria | Hiszpania | |
| CyberKnife | od $4,750 | od $50,000 | od $30,000 |
| CyberKnife w raku prostaty | od $25,000 | od $25,000 | od $15,000 |
| CyberKnife przy nowotworach mózgu | od $4,750 | od $35,000 | od $30,000 |
| CyberKnife w leczeniu raka płuc | od $6,000 | - | od $8,033 |
1 dzień
Dzień 2
Dzień 3
Dzień 4
Dzień 5
1-2 tydzień
3-4 tydzień
5-6 tydzień
Uwaga: Powyższy harmonogram jest ogólnym przewodnikiem. Każdy przypadek pacjenta jest unikalny i terminy mogą się różnić. Regularne transfery są zapewniane, ale zakwaterowanie nie jest wliczone w usługę.
Specjalizuje się w zabiegach CyberKnife w Hisar Hospital Intercontinental, wykorzystując wiedzę zdobytą podczas szkolenia w MD Anderson Cancer Center.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Dr Mehmet Tonge specjalizuje się w neurochirurgii stereotaktycznej i funkcjonalnej, prowadząc szeroko zakrojone badania i koncentrując się klinicznie na radiochirurgii Gamma Knife.
Specjalizuje się w leczeniu CyberKnife, posiadając doświadczenie w neurochirurgii stereotaktycznej i funkcjonalnej – szkolony w Szkole Medycznej w Hanowerze.